PTPRC and acute myeloid leukemia: At the same time point, resident murine CD45+ cells co-extracted from aspirated tibias had significantly higher colony forming potential upon the addition of CKS1i compared to untreated mice and DA treated mice (Figure 7C), indicating that CKS1i treatment can selectively reduce AML, whilst simultaneously protecting normal HSPCs colony forming potential.